Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Osijek – page 2

85 clinical trials in Osijek, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Osijek at a glance
85
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

85 trials in Osijek

Open in trial search

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Coeliac disease

Recruiting

Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:CroatiaCroatia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:BI 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

A Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Colitis ulcerative+1

Recruiting

Study of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:MT-501
  • Sponsor:Mirador Therapeutics Inc.

Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Osijek

What the registry says about research in the country

01 Autoimmune Disorders

Clinical research focusing on innovative treatments for psoriatic arthritis, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new therapeutic approaches targeting specific immune pathways.

  • Psoriatic Arthritis Treatment
  • Systemic Sclerosis Management
  • Sjögren's Syndrome Therapy

Investigations include both biologic and non-biologic treatment options for patients with varying disease severity.

02 Gastrointestinal Disorders

Comprehensive studies examining treatments for Crohn's Disease and Ulcerative Colitis. Research focuses on novel therapeutic compounds and combination treatments.

  • Inflammatory Bowel Disease Management
  • Novel Treatment Combinations
  • Pediatric Gastrointestinal Conditions

Trials aim to improve clinical outcomes and quality of life for patients with moderate to severe disease.

03 Neurological Conditions

Advanced research into Multiple Sclerosis and tardive dyskinesia treatments. Studies evaluate new therapeutic approaches and compare treatment efficacy.

  • MS Treatment Innovations
  • Movement Disorders
  • Neurological Disease Management

Focus on developing treatments that can slow disease progression and improve symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.